Page last updated: 2024-11-07

fluprednisolone and Multiple Sclerosis

fluprednisolone has been researched along with Multiple Sclerosis in 1 studies

Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TOURTELLOTTE, WW1
HAERER, AF1
SIMPSON, JF1
KUZMA, JW1
SIKORSKI, J1

Other Studies

1 other study available for fluprednisolone and Multiple Sclerosis

ArticleYear
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL.
    Annals of the New York Academy of Sciences, 1965, Mar-31, Volume: 122

    Topics: Adrenocorticotropic Hormone; Biomedical Research; Drug Therapy; Fluprednisolone; Humans; Methylpredn

1965